| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.6B | $9.7B | $8.7B | $9.3B | $5.8B | $7.3B | $6.7B | $6.1B |
| Cost of Revenue | $6.0B | $5.6B | $5.2B | $5.4B | $3.6B | $4.2B | $3.9B | — |
| Gross Profit | — | — | — | — | $1.0B | $0.9B | $0.8B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.5B | $3.3B | $2.9B | $2.9B | $2.3B | $2.2B | $2.0B | $1.9B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.3B | $0.2B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $7.91 | $5.25 | $3.51 | $6.14 | $2.35 | $3.14 | $2.77 | $3.58 |
| EPS (Diluted) | $7.80 | $5.23 | $3.49 | $6.00 | $2.33 | $3.08 | $2.70 | $3.47 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B | $7.7B | $7.3B | $7.1B | $6.8B | $5.6B | $3.1B | $2.8B |
| Current Assets | $2.6B | $2.3B | $2.3B | $2.5B | $2.5B | $1.4B | $1.3B | $1.1B |
| Cash & Equivalents | $1.0B | $0.9B | $0.9B | $1.1B | $1.4B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.3B | $2.0B | $1.9B | $1.9B | $1.7B | $1.5B | $1.2B | $1.1B |
| Stockholders' Equity | $1.4B | $1.0B | $0.8B | $0.8B | $0.5B | $0.5B | $0.3B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.6B | $0.8B | $0.2B | $0.9B | $0.6B | — |
| Investing Cash Flow | $-0.9B | $-0.5B | $-0.4B | $-0.3B | $-0.3B | $-0.3B | $-0.3B | — |
| Capital Expenditures | $0.9B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Financing Cash Flow | $0.1B | $-0.3B | $-0.4B | $-0.8B | $1.0B | $-0.3B | $-0.4B | — |